Related Experiment Video
Updated: Jun 26, 2026

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
The Road to Cancer Care: Understanding How Far Owners Travel for Their Pets' Oncology Treatment
Angus Lane1, Kelly L Bowlt Blacklock1, Laura Blackwood1
1Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Roslin EH25 9RG, UK.
Abstract:
Access to specialist veterinary oncology services may be influenced by geographic, demographic, and patient-related factors. Understanding travel burden is important for identifying potential barriers to care and designing more equitable service delivery models. This study quantified the distance travelled by owners seeking specialist oncology care at a UK veterinary teaching hospital and examined whether species, age, breed, and insurance status were associated with travel patterns. A retrospective review was conducted of all dogs and cats presenting to the Oncology Service at the Hospital for Small Animals, University of Edinburgh, between 1 December 2018 and 31 October 2025. Owner postcodes were used to calculate distances from residence to the hospital. Distances were compared across species (dog vs. cat), breed (pure-breed vs. mixed-breed), age (<7 vs. ≥7 years), and insurance status (insured vs. uninsured). A total of 3074 cases were included. In univariate analysis, dogs travelled significantly further than cats (p < 0.001), pure-breed animals travelled significantly further than mixed-breed animals (p < 0.001), and younger animals travelled significantly further than older animals (p = 0.002). In multivariate analysis, species, age, and insurance status were significant, with dogs (p < 0.001), younger animals (p = 0.012), and uninsured animals (p = 0.008) travelling further. These findings highlight potential geographic inequities in access to specialist care and underscore the need for alternative service-delivery strategies to improve accessibility, particularly for cats and younger animals.
Related Concept Videos
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

